Role of Dkk3 protein in regulation of lymphocyte cytotoxicity: systematic review
Keywords:
Dkk3, Wnt signaling pathway, cytotoxic lymphocytes, oncogene, tumor suppressor geneAbstract
The study of the role of the Dkk 3 protein in the regulation of lymphocyte cytotoxicity is an urgent, little-studied area in science. It is an extremely difficult task for researchers to understand the molecular and genetic aspects of the functioning of this protein, as well as to identify the relationship between Dkk3 and the human immune system. The Dickkopf protein family is diverse and includes five proteins. Dkk3 interacts with the Wnt signaling pathway, which distinguishes this protein from other Dkk members. In addition, Dkk3 has a variety of biological roles (prevents cardiac hypertrophy and promotes stem cell differentiation). This protein can act as a modulator of the immune system. Dkk3 plays an important role in establishing peripheral tolerance of T cells. This paper provides a systematic review of scientific publications in the PubMed database devoted to the study of the role of Dkk3 in the regulation of lymphocyte cytotoxicity, published from 2020 to 2025. During the systematic review, 182 sources were studied, from which 41 articles included in the study were selected during the screening process. The search queries and keywords contained «Dkk3 as an extracellular antagonist of Wnt», «regulatory pathways through Dkk3», «tumor suppressor gene», «oncogene», «relationship of Dkk3 with a subpopulation of lymphocytes», «cytotoxic lymphocytes». A systematic review will expand the field of research on the biological role of Dkk3, in particular on the role of Dkk3 in regulating lymphocyte cytotoxicity, for further study and discovery of new directions on this research topic.
References
- Mourtada J, et al. The Multifaceted Role of Human Dickkopf-3 (DKK-3) in Development, Immune Modulation and Cancer. Cells. 2024;13(1):1–14. DOI: 10.3390/cells13010075.
- Han M, et al. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach. Cancer Immunology, Immunotherapy. 2022;71:3013–3027. DOI: 10.1007/s00262-022-03222-4.
- Katase N, et al. Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC). Cancer Cell International. 2022;22(352):1–16. DOI: 10.1186/s12935-022-02783-9.
- Xia Pu, Xu X. Use of tumor suppressor genes of naked mole rats for human cancer treatment. American Journal of Translational Research. 2023;15(8):5356–5363. https://pmc.ncbi.nlm.nih.gov/articles/PMC10492090/.
- Soheilifar MH, et al. miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI. BioImpacts. 2022;12(4):349–358. DOI: 10.34172/bi.2021.23571.
- Shareef ZA, et al. DKK3’s protective role in prostate cancer is partly due to the modulation of immunerelated pathways. Frontiers in Immunology. 2023;14:1–12. DOI: 10.3389/fimmu.2023.978236.
- Zhao S, et al. The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer. Frontiers in Oncology. 2020;10:1–13. DOI: 10.3389/fonc.2020.600322.
- Xia Z, et al. WIF1 and DKK3 in prostate cancer: from molecular pathways to therapeutic targets: a narrative review. Translational Andrology and Urology. 2024;13(11):2601–2616. DOI: 10.21037/tau-24-304.
- Kafka A, et al. Methylation Patterns of DKK1, DKK3 and GSK3b Are Accompanied with Different Expression Levels in Human Astrocytoma. Cancers. 2021;13(2530):1–17. DOI: 10.3390/cancers13112530.
- Pei Y, et al. MicroRNA miR-425 promotes tumor progression by inhibiting Dickkopf-related protein-3 in gastric cancer. Bioengineered. 2021;12(1):2045–2054. DOI: 10.1080/21655979.2021.1930743.
- Sehgal P, et al. MYC hyperactivates WNT signaling in APC/CTNNB1-mutated colorectal cancer cells through miR-92a- dependent repression of DKK3. Мolecular cancer research. 2022;19(12):1–25. DOI: 10.1158/1541-7786.MCR-21-0666.
- Shen F, et al. MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer. Oncology Letters. 2020;20(5):1–8. DOI: 10.3892/ol.2020.12086.
- Kano J, et al. Roles of DKK3 in cellular adhesion, motility, and invasion through extracellular interaction with TGFBI. The FEBS Journal. 2022;289(20):6385–6399. DOI: 10.1111/febs.16529.
- Conde J, et al. Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway Javier. Chondrocytes. 2021;13(2):925–934. DOI: 10.1177/1947603520933328.
- Zhang L, et al. DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. Journal of Neuroinflammation. 2022;19(129):1–24. DOI: 10.1186/s12974-022-02495-x.
- Gondkar K, et al. Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer. Cells. 2021;10(511):1–16. DOI: 10.3390/cells10030511.
- Mourtada J, et al. A novel DNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer. Frontiers in Immunology. 2023;14:1–18. DOI: 10.3389/fimmu.2023.1264093.
- Zhou Y, et al. Identification of Key Genes and Pathways Associated with PIEZO1 in Bone-Related Disease Based on Bioinformatics. International Journal of Molecular Sciences. 2022;23(5220):1–15. DOI: 10.3390/ijms23095250.
- Kang L, et al. NRF1 knockdown alleviates lipopolysaccharide-induced pulmonary inflammatory injury by upregulating DKK3 and inhibiting the GSK-3β/β-catenin pathway. Clinical and Experimental Immunology. 2023;214(1):120–129. DOI: 10.1093/cei/uxad071.
- Han M, et al. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower- grade gliomas. BMC Neurology. 2023;23(183):1–14. DOI: 10.1186/s12883-023-03236-0.
- Liu Q, et al. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/ β-catenin signaling pathway in mice. Stem Cell Research & Therapy. 2022;13(224):1–18. DOI: 10.1186/s13287-022-02906-z.
- Caffo M, et al. Molecular Investigation of DKK3 in Cerebral Ischemic/Reperfusion Injury. Biomedicines. 2023;11(815):1–9. DOI: 10.3390/biomedicines11030815.
- Shareef A, et al. Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment. Cancers. 2022;14(5822):1–16. DOI: 10.3390/cancers14235822.
- Takeuchi A, et al. Suppressed Cellular Senescence Mediated by T-box3 in Aged Gastric Epithelial Cells may Contribute to Aging-related Carcinogenesis. Cancer research communications. 2022;2(8):772–783. DOI: 10.1158/2767-9764.CRC-22-0084.
- Kafka A, et al. SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter. Frontiers in molecular neuroscience. 2024;17:1–15. DOI: 10.3389/fnmol.2024.1398872/full.
- Li Y, et al. Apogossypolone Inhibits Cell Proliferation and Epithelial- Mesenchymal Transition in Cervical Cancer via Activating DKK3. Frontiers in oncology. 2022;12:1–11. DOI: 10.3389/fonc.2022.948023/full.
- Caffo M, et al. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers. International Journal of Molecular Sciences. 2024;25(4091):1–16. DOI: 10.3390/ijms25074091.
- Song J, et al. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway- dependent manner. Renal failure. 2024;46(1):1–15. DOI: 10.1080/0886022X.2024.2343817.
- Shailesh H, Kodappully S, Sif S. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3. Journal of Cellular and Molecular Medicine. 2021;25:1583–1600. DOI: 10.1111/jcmm.16260.
- Cooney RA, et al. A WNT4- and DKK3-driven canonical to noncanonical Wnt signaling switch controls multiciliogenesis. Journal of Cell Science. 2023;136:1–15. DOI: 10.1242/jcs.260807.
- Zhang Z, et al. DKK3 promotes adipogenic differentiation of stem cells by inhibiting Wnt/β-catenin signaling pathway related gene expression and mitochondrial autophagy. Poultry science. 2024;103(12):1–13. DOI: 10.1016/j.psj.2024.104257.
- Zhu P, et al. Circular RNA Hsa_circ_0004018 Inhibits Wnt/β- Catenin Signaling Pathway by Targeting microRNA-626/DKK3 in Hepatocellular Carcinoma. OncoTargets and Therapy. 2020;13:9351–9364. DOI: 10.2147/OTT.S254997.
- Guo Q, et al. Dickkopf-related protein 3 alters aerobic glycolysis in pancreatic cancer BxPC-3 cells, promoting CD4+ T-cell activation and function. European Journal of Medical Research. 2021;26(93):1–10. DOI: 10.1186/s40001-021-00567-x.
- Chen X, et al. The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity. Journal of Clinical Investigation. 2022;132(18):1–12. DOI: 10.1172/JCI147566.
- Timothy N, et al. Dormant tumors circumvent tumorspecific adaptive immunity by establishing a Treg-dominated niche via DKK3. JCI Insight. 2023;8(22):1–20. DOI: 10.1172/jci.insight.174458.
- Liu D, et al. Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer. The International Journal of Biological Markers. 2023;38(2):99–104. DOI: 10.1177/03936155231169796.
- PRISMA [Internet, cited 2024 December 23]. Available from: https://www.prisma-statement.org/.
- Dellinger TH, et al. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Gynecologic oncology. 2012;126(2):259–267. DOI: 10.1016/j. ygyno.2012.04.026.
- Hayat R, Manzoor M, Hussain A. Wnt signaling pathway. A comprehensive review. Cell biology international. 2022;46(6):863–877. DOI: 10.1002/cbin.11797.
- Meister M, et al. Dickkopf-3, a tissue-derived modulator of local T-cell responses. Frontiers in Immunology. 2015;6(78):1–13. DOI: 10.3389/fimmu.2015.00078.
- Atlas of Genetics and Cytogenetics in Oncology and Haematology [Internet, cited 2024 December 13]. Available from: https:// atlasgeneticsoncology.org/gene/40327/dkk3.